Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Perry

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
DICP : the Annals of Pharmacotherapy|November 1, 1991
Triazolam--the never-ending storyP J Perry, D A Smith
Expert Opinion on Pharmacotherapy|March 16, 2001
Olanzapine: an atypical antipsychotic for schizophreniaB C Lund, P J Perry
The Annals of Pharmacotherapy|April 1, 1992
The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroidsD A Smith, P J Perry
Drug Intelligence & Clinical Pharmacy|February 12, 1975
Activities of the clinical pharmacist practicing in the office of a family practitionerP J Perry, S C Hurley
Clinical Pharmacy|November 1, 1993
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomniaJ D Hoehns, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 15, 1995
Nefazodone: a new antidepressantV L Ellingrod, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 1997
Dexfenfluramine hydrochloride: an anorexigenic agentK A Bever, P J Perry
American Journal of Hospital Pharmacy|December 15, 1994
Venlafaxine: a heterocyclic antidepressantV L Ellingrod, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 2, 1998
Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapyK A Bever, P J Perry
The Annals of Pharmacotherapy|May 1, 1992
The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agentsD A Smith, P J Perry
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
DICP : the Annals of Pharmacotherapy|November 1, 1991
Triazolam--the never-ending storyP J Perry, D A Smith
Expert Opinion on Pharmacotherapy|March 16, 2001
Olanzapine: an atypical antipsychotic for schizophreniaB C Lund, P J Perry
The Annals of Pharmacotherapy|April 1, 1992
The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroidsD A Smith, P J Perry
Drug Intelligence & Clinical Pharmacy|February 12, 1975
Activities of the clinical pharmacist practicing in the office of a family practitionerP J Perry, S C Hurley
Clinical Pharmacy|November 1, 1993
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomniaJ D Hoehns, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 15, 1995
Nefazodone: a new antidepressantV L Ellingrod, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 1997
Dexfenfluramine hydrochloride: an anorexigenic agentK A Bever, P J Perry
American Journal of Hospital Pharmacy|December 15, 1994
Venlafaxine: a heterocyclic antidepressantV L Ellingrod, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 2, 1998
Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapyK A Bever, P J Perry
The Annals of Pharmacotherapy|May 1, 1992
The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agentsD A Smith, P J Perry
Pageof 13